I love it when clinics keep things this simple
If you notice that hair loss does not get better, you should talk to your healthcare provider
CLINICAL TRIAL EVIDENCE FOR GLP-1 RAs IN MASH Table 2 provides a summary of phase 2 and phase 3 studies examining GLP-1 RAs and dual or triple agonists (aiming glucagon, GIP, and GLP-1 receptors) in individuals with MASLD/MASH, where hepatic biopsies were used to evaluate liver outcomes [3,5,10,11,15,22-25,44-52]
Separating Science From Marketing Despite its promising biology, GHK-Cu is often marketed with exaggerated claims
Nothing crazy, but enough to leave me with a nasty second-degree burn about the size of my palm